These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 24498263

  • 1. Role of the stem cell-associated intermediate filament nestin in malignant proliferation of non-small cell lung cancer.
    Chen Z, Wang J, Cai L, Zhong B, Luo H, Hao Y, Yu W, Wang B, Su C, Lei Y, Bella AE, Xiang AP, Wang T.
    PLoS One; 2014; 9(2):e85584. PubMed ID: 24498263
    [Abstract] [Full Text] [Related]

  • 2. RNAi-mediated human Nestin silence inhibits proliferation and migration of malignant melanoma cells by G1/S arrest via Akt-GSK3β-Rb pathway.
    Yang XH, Xia T, Zhang J, Yang SF, Tang HX, Tang T, Huang ZC, Zhong YS, He F, Xiang AP.
    J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):895-903. PubMed ID: 29270750
    [Abstract] [Full Text] [Related]

  • 3. Nestin regulates proliferation, migration, invasion and stemness of lung adenocarcinoma.
    Narita K, Matsuda Y, Seike M, Naito Z, Gemma A, Ishiwata T.
    Int J Oncol; 2014 Apr; 44(4):1118-30. PubMed ID: 24481417
    [Abstract] [Full Text] [Related]

  • 4. Involvement of intermediate filament nestin in cell growth of small-cell lung cancer.
    Takakuwa O, Maeno K, Kunii E, Ozasa H, Hijikata H, Uemura T, Kasai D, Ohkubo H, Miyazaki M, Oguri T, Niimi A.
    Lung Cancer; 2013 Aug; 81(2):174-9. PubMed ID: 23706418
    [Abstract] [Full Text] [Related]

  • 5. Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling.
    Zhao Y, Ye X, Chen R, Gao Q, Zhao D, Ling C, Qian Y, Xu C, Tao M, Xie Y.
    Oncol Rep; 2020 Sep; 44(3):959-972. PubMed ID: 32705247
    [Abstract] [Full Text] [Related]

  • 6. GSK3β overexpression indicates poor prognosis and its inhibition reduces cell proliferation and survival of non-small cell lung cancer cells.
    Zeng J, Liu D, Qiu Z, Huang Y, Chen B, Wang L, Xu H, Huang N, Liu L, Li W.
    PLoS One; 2014 Sep; 9(3):e91231. PubMed ID: 24618715
    [Abstract] [Full Text] [Related]

  • 7. Leucine zipper tumor suppressor 2 inhibits cell proliferation and regulates Lef/Tcf-dependent transcription through Akt/GSK3β signaling pathway in lung cancer.
    Cui QZ, Tang ZP, Zhang XP, Zhao HY, Dong QZ, Xu K, Wang EH.
    J Histochem Cytochem; 2013 Sep; 61(9):659-70. PubMed ID: 23761130
    [Abstract] [Full Text] [Related]

  • 8. Cell adhesion molecule 4 suppresses cell growth and metastasis by inhibiting the Akt signaling pathway in non-small cell lung cancer.
    Luo F, Zhao Y, Liu J.
    Int J Biochem Cell Biol; 2020 Jun; 123():105750. PubMed ID: 32325280
    [Abstract] [Full Text] [Related]

  • 9. MiR-30a suppresses non-small cell lung cancer progression through AKT signaling pathway by targeting IGF1R.
    Wen XP, Ma HL, Zhao LY, Zhang W, Dang CX.
    Cell Mol Biol (Noisy-le-grand); 2015 May 28; 61(2):78-85. PubMed ID: 26025408
    [Abstract] [Full Text] [Related]

  • 10. NLK functions to maintain proliferation and stemness of NSCLC and is a target of metformin.
    Suwei D, Liang Z, Zhimin L, Ruilei L, Yingying Z, Zhen L, Chunlei G, Zhangchao L, Yuanbo X, Jinyan Y, Gaofeng L, Xin S.
    J Hematol Oncol; 2015 Oct 26; 8():120. PubMed ID: 26503334
    [Abstract] [Full Text] [Related]

  • 11. B-Myb Mediates Proliferation and Migration of Non-Small-Cell Lung Cancer via Suppressing IGFBP3.
    Fan X, Wang Y, Jiang T, Cai W, Jin Y, Niu Y, Zhu H, Bu Y.
    Int J Mol Sci; 2018 May 16; 19(5):. PubMed ID: 29772705
    [Abstract] [Full Text] [Related]

  • 12. STIP overexpression confers oncogenic potential to human non-small cell lung cancer cells by regulating cell cycle and apoptosis.
    Tang Y, Yan G, Song X, Wu K, Li Z, Yang C, Deng T, Sun Y, Hu X, Yang C, Bai H, Li H, Tan W, Ye M, Liu J.
    J Cell Mol Med; 2015 Dec 16; 19(12):2806-17. PubMed ID: 26354852
    [Abstract] [Full Text] [Related]

  • 13. Overexpression of PP2A inhibitor SET oncoprotein is associated with tumor progression and poor prognosis in human non-small cell lung cancer.
    Liu H, Gu Y, Wang H, Yin J, Zheng G, Zhang Z, Lu M, Wang C, He Z.
    Oncotarget; 2015 Jun 20; 6(17):14913-25. PubMed ID: 25945834
    [Abstract] [Full Text] [Related]

  • 14. Parthenolide suppresses non-small cell lung cancer GLC-82 cells growth via B-Raf/MAPK/Erk pathway.
    Lin M, Bi H, Yan Y, Huang W, Zhang G, Zhang G, Tang S, Liu Y, Zhang L, Ma J, Zhang J.
    Oncotarget; 2017 Apr 04; 8(14):23436-23447. PubMed ID: 28423582
    [Abstract] [Full Text] [Related]

  • 15. Overexpression of MYCN promotes proliferation of non-small cell lung cancer.
    Liu K, Wang S, Liu Y, Gu J, Gu S, Xu Z, Zhang R, Wang Z, Ma H, Chen Y, Ji L.
    Tumour Biol; 2016 Sep 04; 37(9):12855-12866. PubMed ID: 27449038
    [Abstract] [Full Text] [Related]

  • 16. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
    Gao BB, Wang SX.
    Eur Rev Med Pharmacol Sci; 2019 Feb 04; 23(3):1093-1101. PubMed ID: 30779077
    [Abstract] [Full Text] [Related]

  • 17. ZNF452 facilitates tumor proliferation and invasion via activating AKT-GSK3β signaling pathway and predicts poor prognosis of non-small cell lung cancer patients.
    Zhang X, Zhou H, Zhang Y, Cai L, Jiang G, Li A, Miao Y, Li Q, Qiu X, Wang E.
    Oncotarget; 2017 Jun 13; 8(24):38863-38875. PubMed ID: 28418919
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of FASN suppresses the malignant biological behavior of non-small cell lung cancer cells via deregulating glucose metabolism and AKT/ERK pathway.
    Chang L, Fang S, Chen Y, Yang Z, Yuan Y, Zhang J, Ye L, Gu W.
    Lipids Health Dis; 2019 May 24; 18(1):118. PubMed ID: 31122252
    [Abstract] [Full Text] [Related]

  • 19. Long Noncoding RNA FAL1 Promotes Cell Proliferation, Invasion and Epithelial-Mesenchymal Transition Through the PTEN/AKT Signaling Axis in Non-Small Cell Lung Cancer.
    Pan C, Yao G, Liu B, Ma T, Xia Y, Wei K, Wang J, Xu J, Chen L, Chen Y.
    Cell Physiol Biochem; 2017 May 24; 43(1):339-352. PubMed ID: 28854421
    [Abstract] [Full Text] [Related]

  • 20. miR‑505 inhibits cell growth and EMT by targeting MAP3K3 through the AKT‑NFκB pathway in NSCLC cells.
    Tang H, Lv W, Sun W, Bi Q, Hao Y.
    Int J Mol Med; 2019 Mar 24; 43(3):1203-1216. PubMed ID: 30628663
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.